Lisa Peterson Rumin

McDermott Will & Emery (Washington)
Lawyer (Associate)

Lisa P. Rumin is an Associate with McDermott Will & Emery in Washington, D.C. She focuses her practice on antitrust, regulatory and litigation matters. She assists clients across a variety of industries and has represented numerous clients in the healthcare, pharmaceutical, and biotechnology industries. Lisa advises clients on mergers and acquisitions, including obtaining clearance from the Federal Trade Commission (FTC) and Department of Justice (DOJ), as well as counsels clients on issues regarding antitrust compliance, pricing, and distribution. She also counsels clients on cartel prosecutions and defenses, including government investigations and the initiation and defense of civil class action litigation. Lisa is experienced in areas of e-discovery, document review and production for investigations before the FTC, DOJ and state attorneys general office.


Linked authors

McDermott Will & Emery (Washington)
McDermott Will & Emery (Washington)


406 Bulletin

Stefan M. Meisner, Anthony S. Ferrara, Lisa Peterson Rumin The US District Court for the Eastern District of Texas declares that a licensing offer based on end-device is compliant with FRAND commitments (HTC / Ericsson)


Standard-essential patent holders and implementers may face uncertainty regarding licensing practices following a May 23 Texas court ruling. In the ruling, a Texas federal judge reached a conclusion different from a recent California court decision — FTC v. Qualcomm — on the question of whether (...)

Stefan M. Meisner, Lisa Peterson Rumin The US Northern District Court of California requires the holder of a standard-essential patent for cellular communication to license it to all those willing to pay a fair, reasonable and non-discriminatory rate (Qualcomm)


This article has been nominated for the 2019 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. FTC Secures Partial Victory Requiring SEP Holder to License to All Comers in Antitrust Case* Summary Recently, a federal district court in California granted (...)

Lisa Peterson Rumin The US District Court for the Northern District of California finds lack of antitrust standing for price-fixed component parts in states that apply the AGC 5-factor test but allowed standing in states that do not (Los Gatos Mercantile / DuPont)


On Sept. 22, 2014, the U.S. District Court for the Northern District of California issued an important opinion regarding antitrust standing in Los Gatos Mercantile, Inc. v. E.I. DuPont de Nemours & Co. (DuPont), No. 13-cv-01180-BLF (N.D. Cal. Sept. 22, 2014). The DuPont opinion is one of (...)

Lisa Peterson Rumin The US District Court for the Eastern District of Pennsylvania dismisses allegations of hub-and-spoke conspiracy against 5 pharmaceutical companies in the market for narcolepsy drugs (Apotex / Cephalon)


On Monday, June 23, 2014, a Federal Judge in the Eastern District of Pennsylvania granted summary judgment for five pharmaceutical companies on horizontal conspiracy claims brought by Apotex Inc. and direct purchaser and end payor plaintiffs regarding the popular narcolepsy drug Provigil. (...)

Send a message